Search results

Evidence-based recommendations on stapled haemorrhoidopexy for treating haemorrhoids in adults.

Result type

Technology appraisal guidance

Published

26 September 2007

Evidence-based recommendations on bortezomib monotherapy (Velcade) for treating relapsed multiple myeloma in adults.

Result type

Technology appraisal guidance

Published

23 October 2007

Evidence-based recommendations on infliximab for treating severe psoriasis in adults.

Result type

Technology appraisal guidance

Published

23 January 2008

Evidence-based recommendations on somatrogon (Ngenla) for treating growth disturbance in children and young people aged 3 years and over.

Result type

Technology appraisal guidance

Published

1 February 2023

Evidence-based recommendations on nintedanib (Ofev) for treating idiopathic pulmonary fibrosis in adults when forced vital capacity is above 80% predicted.

Result type

Technology appraisal guidance

Published

1 February 2023

Evidence-based recommendations on nivolumab (Opdivo) with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

8 February 2023

Evidence-based recommendations on etanercept (Enbrel), infliximab (Remicade) and adalimumab (Humira) for treating active and progressive psoriatic arthritis in adults.

Result type

Technology appraisal guidance

Published

25 August 2010

Evidence-based recommendations on nivolumab (Opdivo) with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma in adults.

Result type

Technology appraisal guidance

Published

11 January 2023

Evidence-based recommendations on lenvatinib (Kisplyx) with pembrolizumab (Keytruda) for untreated advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

11 January 2023

Evidence-based recommendations on maribavir (Livtencity) for cytomegalovirus infection in adults after transplant.

Result type

Technology appraisal guidance

Published

18 January 2023

Evidence-based recommendations on upadacitinib (Rinvoq) for treating active non-radiographic axial spondyloarthritis in adults.

Result type

Technology appraisal guidance

Published

1 February 2023

Evidence-based recommendations on trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments in adults.

Result type

Technology appraisal guidance

Published

1 February 2023

Evidence-based recommendations on regorafenib (Stivarga) for previously treated metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

8 February 2023

Evidence-based recommendations on vutrisiran (Amvuttra) for treating hereditary transthyretin-related amyloidosis in adults.

Result type

Technology appraisal guidance

Published

15 February 2023

Evidence-based recommendations on Ixazomib (Ninlaro) with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.

Result type

Technology appraisal guidance

Published

22 February 2023